Prognostic significance of ADT In our population, there were nearly significant differences between the bPFS rates for patients who received ADT compared to patients who did not ( Fig 6A ).
← all excerpts
Long-term biochemical progression-free survival following brachytherapy for prostate cancer: Further insight into the role of short-term androgen deprivation and intermediate risk group subclassification.
1
—
—